MYO15A: A Potential Drug Target and Biomarker for Muscle-Related Conditions

Target Name: MYO15A

NCBI ID: G51168

MYO15A

MYO15A: A Potential Drug Target and Biomarker for Muscle-Related Conditions

Myosin XVA (MYO15A) is a protein that is expressed in muscle cells and is involved in muscle contraction and relaxation. It is a key player in the myosin system, which is responsible for generating muscle force during muscle contractions.MYO15A has been identified as a potential drug target and biomarker for several muscle-related conditions, including muscle dystrophy, myopathies, and neuromuscular disorders.

The myosin system is a complex protein that is responsible for generating muscle force during muscle contractions. It consists of several subunits, including Myosin ATPase (MAT), Myosin light chain (MLC), and Myosin heavy chain (MYH).MYO15A is a protein that is expressed in muscle cells and is involved in muscle contraction and relaxation. It is a key player in the myosin system, which is responsible for generating muscle force during muscle contractions.

MYO15A has been identified as a potential drug target and biomarker for several muscle-related conditions, including muscle dystrophy, myopathies, and neuromuscular disorders. It is expressed in muscle cells and is involved in muscle contraction and relaxation. It is a key player in the myosin system, which is responsible for generating muscle force during muscle contractions.

MYO15A as a drug target

MYO15A has been identified as a potential drug target for several muscle-related conditions. One of the main reasons for its potential as a drug target is its involvement in muscle contraction and relaxation. MYO15A is a key player in the myosin system, which is responsible for generating muscle force during muscle contractions. It is expressed in muscle cells and is involved in muscle contraction and relaxation.

MYO15A has been shown to play a role in several muscle-related conditions, including muscle dystrophy, myopathies, and neuromuscular disorders. For example, studies have shown that MYO15A levels are decreased in muscle cells of individuals with dystrophies, such as dystrophin-deficient X -linked dystrophy (XDY) and Becker muscular dystrophy (BMD).

MYO15A has also been shown to be involved in the pathogenesis of myopathies, such as muscle-wasting diseases. For example, studies have shown that MYO15A levels are increased in muscle cells of individuals with muscle-wasting diseases, such as Zukang disease and cancer.

MYO15A has also been shown to be involved in the pathogenesis of neuromuscular disorders, such as spinal muscular atrophy (SMA). For example, studies have shown that MYO15A levels are decreased in muscle cells of individuals with SMA and that its expression is associated with the severity of SMA.

MYO15A as a biomarker

MYO15A has also been identified as a potential biomarker for several muscle-related conditions. It is a protein that is expressed in muscle cells and is involved in muscle contraction and relaxation. It is a key player in the myosin system, which is responsible for generating muscle force during muscle contractions.

MYO15A has been shown to be a potential biomarker for muscle dystrophy, myopathies, and neuromuscular disorders. For example, studies have shown that MYO15A levels are decreased in muscle cells of individuals with dystrophies, such as dystrophin-deficient X-linked dystrophy (XDY) and Becker muscular dystrophy (BMD).

MYO15A has also been shown to be a potential biomarker for muscle-wasting diseases, such as Zukang disease and cancer. For example, studies have shown that MYO15A levels are increased in muscle cells of individuals with muscle-wasting diseases, such as SMA.

MYO15A has also been shown to be a potential biomarker for

Protein Name: Myosin XVA

Functions: Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails are presumed to bind to membranous compartments, which would be moved relative to actin filaments. Required for the arrangement of stereocilia in mature hair bundles (By similarity)

The "MYO15A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MYO15A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets